Published July 9, 2023 | Version v1
Dataset Open

Rana catesbeiana (Lithobates catesbeianus) American bullfrog Genome Version 4

Authors/Creators

  • 1. University of Victoria, Victoria, British Columbia, Canada
  • 2. BC Cancer Agency; Canada`s Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada

Description

Further assembly refinement of Bruno (adult male bullfrog) using 10X Chromium long reads from Bruno Jr. (younger adult male bulfrog). Earlier versions of the genome are available at NCBI Genbank under accession LIAG00000000, BioProject PRJNA285814. 

Notes

Funding provided by Genome British Columbia, Natural Sciences and Engineering Research Council of Canada, and National Human Genome Research Institute of the National Institutes of Health (award number R01HG007182).

Files

Files (9.1 GB)

Name Size
md5:69457c348704eee4f347fe0187f15682
9.1 GB Download

Additional details

References

  • Hammond, S.A., Warren, R.L., Vandervalk, B.P. Kucuk, E., Khan, H., Gibb, E.A., Pandoh, P., Kirk, H., Zhao, Y., Jones, M., Mungall, A.J., Pleasance, S., Moore, R.A., Holt, R.A., Round, J.M., Ohora, S., Walle, B.V., Veldhoen, N., Helbing, C.C., and Birol, I. 2017. North American bullfrog draft genome provides insight into hormonal regulation of long noncoding RNA. Nature Communications, 8: 1433. DOI: 10.1038/s41467-017-01316-7
  • Jackman, S.H.*, Evans, E.P.*, Kuecks-Winger, H., Corrie, L.M., Imbery, J.J., Miliano, R.C., Roberts, B.J., Thompson, V.C., Thambirajah, A.A., Lesperance, M.L., Pyle, G.G., van Aggelen, G., and Helbing, C.C. 2022. Comparison of transcriptome responses of the liver, tailfin, and olfactory epithelium of Rana [Lithobates] catesbeiana tadpoles disrupted by thyroid hormones and estrogen. Aquatic Toxicology, 253: 106344. DOI: 10.1016/j.aquatox.2022.106344
  • Koide, E.M., Abbott, E.A., and Helbing, C.C. 2022. Uncovering early thyroid hormone signalling events through temperature-mediated activation of molecular memory in the cultured bullfrog tadpole tail fin. General and Comparative Endocrinology, 323-324: 114047. DOI: 10.1016/j.ygcen.2022.114047